Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eitan Friedman

Showing results (31-40 of 375) with videos related to

Pageof 38
Sort By:
Genetic Testing and Molecular Biomarkers|July 15, 2009
Haplotype of the C61G BRCA1 mutation in Polish and Jewish individualsBella Kaufman, Yael Laitman, Jacek Gronwald, et al.
Familial Cancer|May 13, 2026
Factors influencing uptake of risk-reducing mastectomy among unaffected Israeli BRCA1/BRCA2 pathogenic variant carriersYael Laitman, Karin Aharon, Talia Schloss, et al.
Psycho-Oncology|December 3, 2011
A follow-up study on men tested for BRCA1/BRCA2 mutations: impacts and coping processesShoshana Shiloh, Efrat Dagan, Irit Friedman, et al.
International Journal of Cancer|December 2, 2009
Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk womenTair Kontorovich, Asaf Levy, Michael Korostishevsky, et al.
Cancers|June 13, 2025
Innovative Approaches to Early Detection of Cancer-Transforming Screening for Breast, Lung, and Hard-to-Screen CancersShlomi Madar, Reef Einoch Amor, Sharon Furman-Assaf, et al.
Clinical Orthopaedics and Related Research|December 15, 2012
Bone turnover markers do not predict stress fracture in elite combat recruitsRan Yanovich, Rachel K Evans, Eitan Friedman, et al.
Genetics Research|May 21, 2015
GREM1 germline mutation screening in Ashkenazi Jewish patients with familial colorectal cancerYael Laitman, Emma Jaeger, Lior Katz, et al.
Plos One|August 6, 2016
Prenatal Cocaine Exposure Upregulates BDNF-TrkB SignalingAndres Stucky, Kalindi P Bakshi, Eitan Friedman, et al.
Genetics Research|May 2, 2020
Germline variant in <i>REXO2</i> is a novel candidate gene in familial pheochromocytomaYael Laitman, Shay Tzur, Ruben Attai, et al.
Familial Cancer|August 8, 2025
Rate of germline pathogenic sequence variants in cancer susceptibility genes in an Israeli pediatric and adolescent cancer cohort: a single institute experienceDana Nahom, Zehavit Frenkel, Amos Toren, et al.
Pageof 38

Showing results (31-40 of 375) with videos related to

Sort By:
Pageof 38
Genetic Testing and Molecular Biomarkers|July 15, 2009
Haplotype of the C61G BRCA1 mutation in Polish and Jewish individualsBella Kaufman, Yael Laitman, Jacek Gronwald, et al.
Familial Cancer|May 13, 2026
Factors influencing uptake of risk-reducing mastectomy among unaffected Israeli BRCA1/BRCA2 pathogenic variant carriersYael Laitman, Karin Aharon, Talia Schloss, et al.
Psycho-Oncology|December 3, 2011
A follow-up study on men tested for BRCA1/BRCA2 mutations: impacts and coping processesShoshana Shiloh, Efrat Dagan, Irit Friedman, et al.
International Journal of Cancer|December 2, 2009
Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk womenTair Kontorovich, Asaf Levy, Michael Korostishevsky, et al.
Cancers|June 13, 2025
Innovative Approaches to Early Detection of Cancer-Transforming Screening for Breast, Lung, and Hard-to-Screen CancersShlomi Madar, Reef Einoch Amor, Sharon Furman-Assaf, et al.
Clinical Orthopaedics and Related Research|December 15, 2012
Bone turnover markers do not predict stress fracture in elite combat recruitsRan Yanovich, Rachel K Evans, Eitan Friedman, et al.
Genetics Research|May 21, 2015
GREM1 germline mutation screening in Ashkenazi Jewish patients with familial colorectal cancerYael Laitman, Emma Jaeger, Lior Katz, et al.
Plos One|August 6, 2016
Prenatal Cocaine Exposure Upregulates BDNF-TrkB SignalingAndres Stucky, Kalindi P Bakshi, Eitan Friedman, et al.
Genetics Research|May 2, 2020
Germline variant in <i>REXO2</i> is a novel candidate gene in familial pheochromocytomaYael Laitman, Shay Tzur, Ruben Attai, et al.
Familial Cancer|August 8, 2025
Rate of germline pathogenic sequence variants in cancer susceptibility genes in an Israeli pediatric and adolescent cancer cohort: a single institute experienceDana Nahom, Zehavit Frenkel, Amos Toren, et al.
Pageof 38